Bixiye
P78-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2021
Natiijooyinka Raadinta
Soo bandhiga 2331 - 2340 ee natiijooyinka 4128
Bixiye
P79-21 Notice of Admission (NOA) Claims Required for Home Care Claims Effective January 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2021
Bixiye
2021 December Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2021
Bixiye
Elagolix/Relugolix - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Elagolix/Relugolix - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP86-21 Commercial Pharmacy Benefit Exclusion for Mitigare®
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP87-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP88-21 MHCP Pharmacy Benefit Exclusion for Tivdak
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP89-21 Pharmacy Benefit Exclusion for Lantus and Lantus Solostar
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP90-21 Update for New to Market Medical Drugs: Tezepelumab, Faricimab, and Ranibizumab Injection (Susvimo implant)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021